Cochrane Review Group

Vascular

115 systematic reviews in Vascular ask 1,558 questions. 22.2% have no studies to answer them, 18% rest on very low certainty evidence and 23.4% reach moderate or high certainty.

Reviews

115

Questions

1,558

current versions

No studies

22.2%

Moderate or high

23.4%

No studies 346 · 22.2%Ungraded 90 · 5.8%Very low 281 · 18%Low 477 · 30.6%Moderate 313 · 20.1%High 51 · 3.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Search questions in Vascular

Thinnest evidence

All no studies and very low questions

Question	Effect	Evidence	Status / GRADE
Intervention NR Failure of hemostatic intervention ( · vascular surgery patients who undergo creation of an anastomosis The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane	RR 0.46 [0.35, 0.61]	17 studies · 2120 participants	Very low
Intervention NR Death from bleeding complications (up to 30 days · vascular surgery patients who undergo creation of an anastomosis The role of sealants for achieving anastomotic hemostasis in vascular surgery (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Change in claudication distance from baseline (m) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Amputation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Revascularisation‐free survival · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Major adverse limb events (MALE) · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Intervention NR Above‐ankle amputation · people with intermittent claudication Mobile health technologies to improve walking distance in people with intermittent claudication (2024) · Cochrane	no estimate extracted	NR	No studies
Supervised exercise therapy following vascular intervention vs vascular intervention alone MWD ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	2 studies · 89 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone 6MWT ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	1 study · 49 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone PFWD ‐ change from baseline · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	2 studies · 87 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone ABI ‐ absolute value · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	no estimate extracted	2 studies · 110 participants	Very low
Supervised exercise therapy following vascular intervention vs vascular intervention alone Mortality · people with symptomatic peripheral arterial disease§ Effects of additional exercise therapy after a successful vascular intervention for people with symptomatic… (2024) · Cochrane	OR 0.92 [0.42, 2]	6 studies · 346 participants	Very low

Reviews 115

Percutaneous thrombectomy or ultrasound‐accelerated thrombolysis for initial management of acute limb ischaemia

Araujo, ST, Moreno, DH, et al. · Cochrane Database of Systematic Reviews · 2022

Vascular

Thinnest evidence

Reviews 115

Percutaneous thrombectomy or ultrasound‐accelerated thrombolysis for initial management of acute limb ischaemia

Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery

Infusion techniques for peripheral arterial thrombolysis

Surgery for deep venous insufficiency

Injection sclerotherapy for varicose veins

Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts

Cilostazol for intermittent claudication

Compression stockings for preventing deep vein thrombosis in airline passengers

Thrombolytic therapy for pulmonary embolism

Interventions for great saphenous vein incompetence

Vasodilators for primary Raynaud's phenomenon

Slow versus fast subcutaneous heparin injections for prevention of bruising and site pain intensity

Graduated compression stockings for the initial treatment of varicose veins in people without venous ulceration

CHIVA method for the treatment of chronic venous insufficiency

Propionyl‐L‐carnitine for intermittent claudication

Retroperitoneal versus transperitoneal approach for elective open abdominal aortic aneurysm repair

Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE

Treatment for telangiectasias and reticular veins

Ultrasound guidance for arterial (other than femoral) catheterisation in adults

Prehabilitation exercise therapy before elective abdominal aortic aneurysm repair

Surgery for small asymptomatic abdominal aortic aneurysms

Dressings and topical agents for arterial leg ulcers

Chelation therapy for atherosclerotic cardiovascular disease

Phlebotonics for venous insufficiency